Home » Inspiration’s OBI-1 Receives Orphan Drug Designation in Europe
Inspiration’s OBI-1 Receives Orphan Drug Designation in Europe
Inspiration Biopharmaceuticals, Inc. announced Tuesday that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia.
SunHerald
SunHerald
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May